Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount

ILMN

Healthcare
Illumina, Inc. · Diagnostics & Research
Trades
146
Politicians
0
Buys
49
Sells
71
Trades
146
Politicians
0
Buys
49
Sells
71
ILMNvs S&P 500 (normalized)
|to
No price data available
ILMN S&P 500 Buy Sell
Range
PoliticianActionDescriptionAmountTradedFiled
Ro KhannaD
BuyILLUMINA INC TSO VYVANSE CMN$1K - $15KApr 30, 2026May 11, 2026
Ro KhannaD
BuyILLUMINA INC. CMN$1K - $15KFeb 17, 2026Mar 9, 2026
Gilbert CisnerosD
BuyIllumina, Inc.$1K - $15KFeb 10, 2026Mar 9, 2026
Ro KhannaD
BuyILLUMINA INC CMN$1K - $15KJan 29, 2026Feb 6, 2026
Ro KhannaD
BuyILLUMINA INC COMMON$1K - $15KJan 29, 2026Feb 6, 2026
Ro KhannaD
SellILLUMINA INC. CMN$1K - $15KJan 27, 2026Mar 9, 2026
Ro KhannaD
BuyILLUMINA INC. CMN$1K - $15KJan 6, 2026Feb 6, 2026
Ro KhannaD
SellILLUMINA INC/DNA WATER UTILI$1K - $15KDec 29, 2025Feb 6, 2026
Lisa McClainR
SellIllumina, Inc.$1K - $15KOct 31, 2025Nov 21, 2025
Lisa McClainR
SellIllumina, Inc.$1K - $15KOct 30, 2025Nov 21, 2025
100 trades
…

Illumina, Inc. (ILMN) Congressional Stock Trades

This page tracks congressional stock trading activity in Illumina, Inc. (ILMN) in the Healthcare sector. Disclosed Capitol has indexed 146 disclosed congressional trades involving ILMN. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.

As of May 2026 — Disclosed Capitol has tracked 146 disclosed congressional trades in Illumina, Inc. (ILMN) — 71:49 sell-heavy ratio — led by Ro Khanna (D).

Which members of Congress trade Illumina, Inc.?

  • Ro Khanna (D) — 65 disclosed trades in ILMN
  • Michael C. Burgess (R) — 9 disclosed trades in ILMN
  • Donald Sternoff Beyer (D) — 6 disclosed trades in ILMN
  • Kathy Manning (D) — 5 disclosed trades in ILMN
  • Lisa McClain (R) — 4 disclosed trades in ILMN

Recent ILMN congressional trades

DatePoliticianPartyActionAmount
Apr 30, 2026Ro KhannaDBuy$1,001 - $15,000
Feb 17, 2026Ro KhannaDBuy$1,001 - $15,000
Feb 10, 2026Gilbert CisnerosDBuy$1,001 - $15,000
Jan 29, 2026Ro KhannaDPurchase$1,001 - $15,000
Jan 29, 2026Ro KhannaDPurchase$1,001 - $15,000
Jan 27, 2026Ro KhannaDSell$1,001 - $15,000
Jan 6, 2026Ro KhannaDPurchase$1,001 - $15,000
Dec 29, 2025Ro KhannaDSale$1,001 - $15,000
Oct 31, 2025Lisa McClainRSale$1,001 - $15,000
Oct 30, 2025Lisa McClainRSale$1,001 - $15,000

Buy vs. sell ratio & volume

Across the 146 disclosed congressional trades in Illumina, Inc. (ILMN), members of Congress have reported 49 buys and 71 sells. The average 30-day alpha vs. the S&P 500 is -2.59%.

Are Illumina, Inc. insiders buying or selling ILMN?

As of August 2026, corporate insiders at Illumina, Inc. have filed 55 SEC Form 4 transactions in ILMN over the past 12 months — including 55 sells worth $379.0M.

DateInsiderActionValue
2026-08-27Meister Keith A. — DirectorSale$1.1M
2026-08-27Meister Keith A. — DirectorSale$12.4M
2026-08-27Meister Keith A. — DirectorSale$5.6M
2026-08-27Meister Keith A. — DirectorSale$3.9M
2026-08-27Meister Keith A. — DirectorSale$6.6M
2026-08-27Meister Keith A. — DirectorSale$2.2M
2026-08-26Meister Keith A. — DirectorSale$8.6M
2026-08-26Meister Keith A. — DirectorSale$12.0M
2026-08-26Meister Keith A. — DirectorSale$3.3M
2026-08-26Meister Keith A. — DirectorSale$97K

Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.

Does Illumina, Inc. receive U.S. government contracts?

As of August 2026, Illumina, Inc. has 2,131 federal contract award records on file from USAspending.gov — most recently $119K from the Department of Health and Human Services on 2026-08-27.

Award dateAgencyAmount
2026-08-27Department of Health and Human Services · National Institutes of Health$119K
2026-08-20Department of Health and Human Services · National Institutes of Health$312K
2026-08-12Department of Health and Human Services · National Institutes of Health$496K
2026-08-11Department of Agriculture · Agricultural Research Service$118K
2026-08-11Department of Veterans Affairs$255K
2026-08-05Department of Health and Human Services · National Institutes of Health$187K
2026-07-31Department of Health and Human Services · National Institutes of Health$1.3M
2026-07-30Department of Health and Human Services · National Institutes of Health$344K
2026-07-15Department of Health and Human Services · National Institutes of Health$104K
2026-07-15Department of the Interior · U.S. Geological Survey$121K

Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.

Illumina, Inc. financial snapshot (FY2025)

For fiscal year 2025, Illumina, Inc. reported revenue of $4.50B and net income of -$1.16B, per SEC filings.

Revenue
$4.50B
Gross profit
$2.74B
Operating income
-$1.07B
Net income
-$1.16B
Diluted EPS
$-7.34
Gross margin
60.9%
Net margin
-25.8%
Free cash flow
$283.0M

Most recent reported quarter: Q2 FY2026 — revenue $2.25B, net income $340.0M.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.